LeonaBio, Inc.
NASDAQ: LONA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mark J. Litton
- Employees
- 26
- Headquarters
- Bothell, United States
- IPO year
- 2020
- Market cap
- $33.3M
- Website
- https://leonabio.com
Loading LONA…
Loading profile data…Frequently asked questions about LONA
What does LeonaBio, Inc. (LONA) do?
LeonaBio, Inc. operates as a biopharmaceutical firm engaged in clinical-stage development. Its core mission revolves around crafting small molecule therapies aimed at revitalizing neurological function and arresting the advancement of neurodegenerative conditions. The company's active development portfolio encompasses ATH-1105, an experimental t...
Where does LONA trade?
LeonaBio, Inc. (LONA) trades on the NASDAQ Capital Market.
What sector is LONA in?
LeonaBio, Inc. (LONA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of LeonaBio, Inc.?
Mark J. Litton is the chief executive officer of LeonaBio, Inc. (LONA).
Where is LeonaBio, Inc. headquartered?
LeonaBio, Inc. is headquartered in United States.
Does LONA pay a dividend?
LeonaBio, Inc. (LONA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LONA go public?
LeonaBio, Inc. (LONA) completed its initial public offering in 2020.